XML 29 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Net (Loss) Income Per Share
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Net (Loss) Income Per Share Net (Loss) Income Per Share
Basic net (loss) income per common share is computed by dividing the net (loss) income attributable to Vir by the weighted-average number of common shares outstanding during the period, without consideration of common stock equivalents. Diluted net (loss) income per common share is computed by dividing the net (loss) income attributable to Vir by the sum of the weighted-average number of common shares outstanding during the period plus any potential dilutive effects of common stock equivalents outstanding during the period calculated in accordance with the treasury stock method. For periods that the Company was in a net loss position, basic net loss per share is the same as diluted net loss per share as the inclusion of all potential common securities outstanding would have been anti-dilutive. The following is a calculation of the basic and diluted net (loss) income per share (in thousands, except share and per share data):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Net (loss) income attributable to Vir$(163,413)$175,312 $(499,088)$617,440 
Weighted-average shares outstanding, basic134,289,620132,729,530133,969,878132,422,028
Weighted-average effect of dilutive securities:
Options to purchase common stock2,144,3022,227,493
Restricted shares subject to future vesting75,75955,080
Shares to purchase under Employee Stock Purchase Plan13,7267,176
Weighted-average shares outstanding, diluted134,289,620134,963,317133,969,878134,711,777
Net (loss) income attributable to Vir per share, basic$(1.22)$1.32 $(3.73)$4.66 
Net (loss) income attributable to Vir per share, diluted$(1.22)$1.30 $(3.73)$4.58 
Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Options issued and outstanding10,601,0548,381,27510,990,2018,717,954
Restricted shares subject to future vesting5,130,3002,194,0504,112,3152,720,818
Total15,731,35410,575,32515,102,51611,438,772